Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class IL-2 therapeutics, today shared positive results from its Phase 1/2 ...

Researchers at the Francis Crick Institute, working with the Amsterdam University Medical Centre, have found that immune cells are held back from fighting lung tumours by another type of cell in the ...

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term lung disease that makes breathing more difficult. COPD tends to get worse over time, and actions you can take can either speed up or slow ...

Drug Improves Effectiveness of Radiation for Lung Cancer That Has Spread to the Brain Oct. 4, 2024 — The University of Cincinnati's Debanjan Bhattacharya is first author of new research ...

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) ...

Developed by the American Lung Association in partnership with the Prevention Research Center of West Virginia University, this new free education program is available for any school or community to ...

REGiMMUNE’s lead therapy, dubbed RGI-2001, is designed to activate regulatory T cells (Tregs) through a novel mechanism that the company has claimed could also have applications for the ...

While the causes of this disease are complex and not fully understood, lung epithelial cells-;specifically those lining the tiny air sacs where oxygen exchange occurs-;have been found to play a ...

Squamous cell carcinoma (SCC) in the lung is one form of non-small cell lung cancer. Non-small cell lung cancers account for about 85% of lung cancers, many of them associated with smoking. Of these, ...